Promotion in bladder cancer.
D000818:Animals; D002273:Carcinogens / Q000494:pharmacology*; D003043:Cocarcinogenesis; D003494:Cyclamates / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced; D051379:Mice; D009374:Neoplasms, Experimental / Q000209:etiology; D051381:Rats; D012439:Saccharin / Q000494:pharmacology; D012552:Schistosomiasis / Q000150:complications; D013997:Time Factors; D014212:Tretinoin / Q000494:pharmacology; D014364:Tryptophan / Q000494:pharmacology; D001743:Urinary Bladder / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000209:etiology*; D014545:Urinary Calculi / Q000150:complications; D014802:Vitamin A Deficiency / Q000150:complications
D002273:Carcinogens; D003494:Cyclamates; D014212:Tretinoin; D014364:Tryptophan; D003520:Cyclophosphamide; D012439:Saccharin